Statistics
Publications
11
Citations
864
H-Index
11
Active since
2000
Scott Delach is an author at Novartis (Switzerland) specializing in pharmacology, molecular oncology, and oncology.
Publications per year
2000–2023
11
11
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling
Chen Liu, Hengyu Lu, Hongyun Wang et al. · Clinical Cancer Research · 2020 · 165 citations · Full text
Medicine, Oncology, Pharmacology +16
Martha Rook, Scott Delach, Galina Deyneko et al. · American Journal Of Pathology · 2004 · 99 citations · Full text
1–5 of 11